Results 51 to 60 of about 9,967 (136)

Novel Para‐Phenylenediamine‐Based Derivatives as Receptor Tyrosine Kinase‐like Orphan Receptor 1 (ROR1) Inhibitors: An In Vitro Preliminary Characterization

ChemMedChem
ROR1 kinase is an underexplored promising target for the development of novel anticancer drugs, being strongly expressed in several cancer cell lines, but poorly in non‐tumor cells. This property, together with the scarce number of molecules effective against ROR1, leads to the design and development of a research program aimed at the discovery of new ...
Smaldone, Gerardina, Miranda, Maria Rosaria, Di Matteo, Francesca, Napolitano, Valeria, Aliberti, Michela, Musella, Simona, Di Sarno, Veronica, Lauro, Gianluigi, Bifulco, Giuseppe, Pepe, Giacomo, Aquino, Giovanna, Tecce, Mario Felice, Gomez-Monterrey, Isabel Maria, Campiglia, Pietro, Ostacolo, Carmine, Bertamino, Alessia, Vestuto, Vincenzo, CIAGLIA, Tania   +17 more
openaire   +4 more sources

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Receptor tyrosine kinase–like orphan receptor 1 (ROR1) [PDF]

Science-Business eXchange, 2014
openaire   +1 more source

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Receptor tyrosine kinase–like orphan receptor 1 (ROR1) [PDF]

Science-Business eXchange, 2012
openaire   +1 more source

Receptor tyrosine kinase–like orphan receptor 1 (ROR1); ROR2 [PDF]

Science-Business eXchange, 2013
openaire   +1 more source

The multifaceted roles of receptor tyrosine pseudokinases in cellular signalling. [PDF]

Biochem Soc Trans
Park EC, Thompson AP, Murphy JM, Liang LY, Lucet IS.   +4 more
europepmc   +1 more source

Unravelıng non-canonıcal Wnt sıgnalıng ın neural development and dısorders: a revıew of Wnt/PCP and Wnt/ca^²⁺ pathways. [PDF]

Mol Biol Rep
Palabiyik AA, Palabiyik E.
europepmc   +1 more source

TAM receptor tyrosine kinases as potential mediators of the non-lytic spread of non-enveloped viruses. [PDF]

Biochem Soc Trans
Moran SJ, Starbird CA.
europepmc   +1 more source

Preclinical and clinical studies on CAR-NK cell therapy: latest update from 2025 ASH Annual Meeting. [PDF]

Exp Hematol Oncol
Luo H, Ding Y, Zhao X.
europepmc   +1 more source